Effect of Aliskiren on Endothelial Function in Hypertensive Patients with Ischemic Heart Disease.

Trial Profile

Effect of Aliskiren on Endothelial Function in Hypertensive Patients with Ischemic Heart Disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Jul 2014

At a glance

  • Drugs Aliskiren (Primary) ; Valsartan
  • Indications Hypertension; Ischaemic heart disorders
  • Focus Pharmacodynamics
  • Most Recent Events

    • 06 Feb 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top